BioAtla, Inc. is an innovative biopharmaceutical company based in San Diego, California, focused on the development of advanced antibody-based therapies targeting various forms of cancer. Utilizing its proprietary Bispecific T cell Engager (BiTEx™) platform, BioAtla is pioneering treatments that are designed to selectively eliminate cancer cells while minimizing damage to healthy tissue. The company aims to address significant unmet medical needs in oncology with a robust pipeline of product candidates, positioning itself as a leader in the evolving cancer therapeutics landscape.
Click "Analyze" to generate stock analysis
BCAB Price Trend and Signals
BCAB Option Volumes & Open Interests (aggregated)
BCAB Put Call Ratios and IV (aggregated)
BCAB Financials
2025-10-20Bearishprice_signal
Large price change detected: -26.51%.
2025-10-16Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.